Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 137 (RNA5SP137) is a processed pseudogene derived from the 5S ribosomal RNA gene family in the human genome. Unlike functional 5S rRNA genes, which are essential components of the ribosome and play a critical role in ribosomal assembly and protein synthesis[1][3], RNA5SP137 contains mutations that render it non-functional and it does not encode an active RNA or protein product[2][6]. Pseudogenes like RNA5SP137 arise through duplication or retrotransposition events but lose their ability to function due to mutations or lack of required regulatory elements[6]. There is no evidence that this pseudogene serves as a therapeutic target, nor is it associated with disease biomarkers, drug interactions, or known safety issues. Its presence in the genome reflects the evolutionary history of the ribosomal RNA gene family rather than an active biological or disease-related role[6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 137 (RNA5SP137).